193 related articles for article (PubMed ID: 30254005)
1. Ultrasound-Diagnosed Nonalcoholic Fatty Liver Disease Independently Predicts a Higher Risk of Developing Diabetes Mellitus in Nonoverweight Individuals.
Wang L
Acad Radiol; 2019 Jul; 26(7):863-868. PubMed ID: 30254005
[TBL] [Abstract][Full Text] [Related]
2. The impact of non-alcoholic fatty liver disease on incident type 2 diabetes mellitus in non-overweight individuals.
Fukuda T; Hamaguchi M; Kojima T; Hashimoto Y; Ohbora A; Kato T; Nakamura N; Fukui M
Liver Int; 2016 Feb; 36(2):275-83. PubMed ID: 26176710
[TBL] [Abstract][Full Text] [Related]
3. Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease: A post hoc analysis of a cohort study.
Yoshitaka H; Hamaguchi M; Kojima T; Fukuda T; Ohbora A; Fukui M
Medicine (Baltimore); 2017 May; 96(18):e6712. PubMed ID: 28471965
[TBL] [Abstract][Full Text] [Related]
4. Improvement of Nonalcoholic Fatty Liver Disease Reduces the Risk of Type 2 Diabetes Mellitus.
Cho HJ; Hwang S; Park JI; Yang MJ; Hwang JC; Yoo BM; Lee KM; Shin SJ; Lee KJ; Kim JH; Cheong JY; Cho SW; Kim SS
Gut Liver; 2019 Apr; 13(4):440-449. PubMed ID: 30970431
[TBL] [Abstract][Full Text] [Related]
5. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
6. Risk for the development of non-alcoholic fatty liver disease: A prospective study.
Wang J; Ma L; Chen S; Xu L; Miao M; Yu C; Li Y; Xu C
J Gastroenterol Hepatol; 2018 Aug; 33(8):1518-1523. PubMed ID: 29381226
[TBL] [Abstract][Full Text] [Related]
7. Transient remission of nonalcoholic fatty liver disease decreases the risk of incident type 2 diabetes mellitus in Japanese men.
Fukuda T; Hamaguchi M; Kojima T; Mitsuhashi K; Hashimoto Y; Ohbora A; Kato T; Nakamura N; Fukui M
Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1443-1449. PubMed ID: 27603300
[TBL] [Abstract][Full Text] [Related]
8. A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease.
Kim TJ; Sinn DH; Min YW; Son HJ; Kim JJ; Chang Y; Baek SY; Ahn SH; Lee H; Ryu S
J Gastroenterol; 2017 Nov; 52(11):1201-1210. PubMed ID: 28382402
[TBL] [Abstract][Full Text] [Related]
9. Severity of nonalcoholic fatty liver disease on sonography and risk of coronary heart disease.
Lee SH; Yun SJ; Kim DH; Jo HH; Park YS
J Clin Ultrasound; 2017 Sep; 45(7):391-399. PubMed ID: 28369989
[TBL] [Abstract][Full Text] [Related]
10. Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes.
Targher G; Valbusa F; Bonapace S; Bertolini L; Zenari L; Pichiri I; Mantovani A; Zoppini G; Bonora E; Barbieri E; Byrne CD
Nutr Metab Cardiovasc Dis; 2014 Jun; 24(6):663-9. PubMed ID: 24594085
[TBL] [Abstract][Full Text] [Related]
11. Association between nonalcoholic fatty liver disease and incident diabetes mellitus among Japanese: a retrospective cohort study using propensity score matching.
Zheng X; Cao C; He Y; Wang X; Wu J; Hu H
Lipids Health Dis; 2021 Jun; 20(1):59. PubMed ID: 34130693
[TBL] [Abstract][Full Text] [Related]
12. Clinical availability of nonalcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in Korean men: 5-year prospective cohort study.
Park SK; Seo MH; Shin HC; Ryoo JH
Hepatology; 2013 Apr; 57(4):1378-83. PubMed ID: 23213066
[TBL] [Abstract][Full Text] [Related]
13. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular disease in adult patients with type 1 diabetes.
Mantovani A; Mingolla L; Rigolon R; Pichiri I; Cavalieri V; Zoppini G; Lippi G; Bonora E; Targher G
Int J Cardiol; 2016 Dec; 225():387-391. PubMed ID: 27768965
[TBL] [Abstract][Full Text] [Related]
14. Clinical risk scoring for predicting non-alcoholic fatty liver disease in metabolic syndrome patients (NAFLD-MS score).
Saokaew S; Kanchanasuwan S; Apisarnthanarak P; Charoensak A; Charatcharoenwitthaya P; Phisalprapa P; Chaiyakunapruk N
Liver Int; 2017 Oct; 37(10):1535-1543. PubMed ID: 28294515
[TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic Fatty Liver Disease and the Development of Metabolic Comorbid Conditions in Patients With Human Immunodeficiency Virus Infection.
Krahn T; Martel M; Sapir-Pichhadze R; Kronfli N; Falutz J; Guaraldi G; Lebouche B; Klein MB; Wong P; Deschenes M; Ghali P; Sebastiani G
J Infect Dis; 2020 Aug; 222(5):787-797. PubMed ID: 32249283
[TBL] [Abstract][Full Text] [Related]
16. Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease.
Chang Y; Jung HS; Cho J; Zhang Y; Yun KE; Lazo M; Pastor-Barriuso R; Ahn J; Kim CW; Rampal S; Cainzos-Achirica M; Zhao D; Chung EC; Shin H; Guallar E; Ryu S
Am J Gastroenterol; 2016 Aug; 111(8):1133-40. PubMed ID: 27185080
[TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic fatty liver disease and the incidence of myocardial infarction: A cohort study.
Sinn DH; Kang D; Chang Y; Ryu S; Cho SJ; Paik SW; Song YB; Pastor-Barriuso R; Guallar E; Cho J; Gwak GY
J Gastroenterol Hepatol; 2020 May; 35(5):833-839. PubMed ID: 31512278
[TBL] [Abstract][Full Text] [Related]
18. Metabolically healthy obesity is associated with an increased risk of diabetes independently of nonalcoholic fatty liver disease.
Chang Y; Jung HS; Yun KE; Cho J; Ahn J; Chung EC; Shin H; Ryu S
Obesity (Silver Spring); 2016 Sep; 24(9):1996-2003. PubMed ID: 27474900
[TBL] [Abstract][Full Text] [Related]
19. Light-to-Moderate Alcohol Consumption Is Associated With Increased Risk of Type 2 Diabetes in Individuals With Nonalcoholic Fatty Liver Disease: A Nine-Year Cohort Study.
Xu L; Xie J; Chen S; Chen Y; Yang H; Miao M; Zhu Z; Li Y; Yu C; Xu C
Am J Gastroenterol; 2020 Jun; 115(6):876-884. PubMed ID: 32282335
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus].
Guo M; Xi G; Yang N; Yao H
Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):631-5. PubMed ID: 25243967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
